Thanks again SB. Were you happy with your final procedure outcome and importantly would you recommend it to others.
Licensing of Ortho ATI/ACI would seem the way to go and if the company ultimately fire up in big markets such as USA/EU it is reasonable to assume that there will be a need for multiple manufacturing lab sites.
Stem Cell Therapy advancements, page-469
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
-0.050(7.04%) |
Mkt cap ! $139.0M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 69.0¢ | 65.0¢ | $673.7K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5561 | 66.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.5¢ | 5270 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |